232 related articles for article (PubMed ID: 25977529)
21. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
Jahrling PB; Geisbert JB; Swearengen JR; Larsen T; Geisbert TW
J Infect Dis; 2007 Nov; 196 Suppl 2():S400-3. PubMed ID: 17940976
[TBL] [Abstract][Full Text] [Related]
22. Case Report: Use of Plasma Exchange Followed by Convalescent Plasma Therapy in a Critically Ill Patient with Severe Fever and Thrombocytopenia Syndrome-Associated Encephalopathy: Cytokine/Chemokine Concentrations, Viral Loads, and Antibody Responses.
Choi S; Kim MC; Kwon JS; Kim JY; Lee KH; Kim SH
Am J Trop Med Hyg; 2018 Dec; 99(6):1466-1468. PubMed ID: 30277197
[TBL] [Abstract][Full Text] [Related]
23. Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.
Florescu DF; Kalil AC; Hewlett AL; Schuh AJ; Stroher U; Uyeki TM; Smith PW
Clin Infect Dis; 2015 Sep; 61(6):969-73. PubMed ID: 25991468
[TBL] [Abstract][Full Text] [Related]
24. Protective efficacy of neutralizing antibodies against Ebola virus infection.
Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
[TBL] [Abstract][Full Text] [Related]
25. The Plasma Mobile, 'A gift from heaven': The impact of health technology transfer on trial perceptions and expectations during the Ebola-Tx Trial, Conakry.
Marí Sáez A; Ronse M; Delamou A; Haba N; Bigey F; van Griensven J; Peeters Grietens K
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008206. PubMed ID: 32320398
[TBL] [Abstract][Full Text] [Related]
26. Out of Africa--caring for patients with Ebola.
Rubin EJ; Baden LR
N Engl J Med; 2014 Dec; 371(25):2430-2. PubMed ID: 25390461
[No Abstract] [Full Text] [Related]
27. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.
Kraft CS; Hewlett AL; Koepsell S; Winkler AM; Kratochvil CJ; Larson L; Varkey JB; Mehta AK; Lyon GM; Friedman-Moraco RJ; Marconi VC; Hill CE; Sullivan JN; Johnson DW; Lisco SJ; Mulligan MJ; Uyeki TM; McElroy AK; Sealy T; Campbell S; Spiropoulou C; Ströher U; Crozier I; Sacra R; Connor MJ; Sueblinvong V; Franch HA; Smith PW; Ribner BS;
Clin Infect Dis; 2015 Aug; 61(4):496-502. PubMed ID: 25904375
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.
Mupapa K; Massamba M; Kibadi K; Kuvula K; Bwaka A; Kipasa M; Colebunders R; Muyembe-Tamfum JJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S18-23. PubMed ID: 9988160
[TBL] [Abstract][Full Text] [Related]
29. First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.
Dörnemann J; Burzio C; Ronsse A; Sprecher A; De Clerck H; Van Herp M; Kolié MC; Yosifiva V; Caluwaerts S; McElroy AK; Antierens A
J Infect Dis; 2017 Jan; 215(2):171-174. PubMed ID: 28073857
[TBL] [Abstract][Full Text] [Related]
30. Persistent immune responses after Ebola virus infection.
Sobarzo A; Ochayon DE; Lutwama JJ; Balinandi S; Guttman O; Marks RS; Kuehne AI; Dye JM; Yavelsky V; Lewis EC; Lobel L
N Engl J Med; 2013 Aug; 369(5):492-3. PubMed ID: 23902512
[No Abstract] [Full Text] [Related]
31. Saving lives without new drugs.
Cohen J
Science; 2014 Nov; 346(6212):911. PubMed ID: 25414286
[No Abstract] [Full Text] [Related]
32. Reply to Christopher and Kortepeter.
Schooley RT
Clin Infect Dis; 2015 Nov; 61(9):1489-90. PubMed ID: 26175523
[No Abstract] [Full Text] [Related]
33. Will We Be Ready for the Next War?
Christopher GW; Kortepeter MG
Clin Infect Dis; 2015 Nov; 61(9):1488-9. PubMed ID: 26175522
[No Abstract] [Full Text] [Related]
34. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.
Baize S; Leroy EM; Georges-Courbot MC; Capron M; Lansoud-Soukate J; Debré P; Fisher-Hoch SP; McCormick JB; Georges AJ
Nat Med; 1999 Apr; 5(4):423-6. PubMed ID: 10202932
[TBL] [Abstract][Full Text] [Related]
35. Editorial Commentary: All's (Almost) Quiet on the Western Front: Will We Be Ready for the Next War?
Schooley RT
Clin Infect Dis; 2015 Aug; 61(4):503-5. PubMed ID: 25904373
[No Abstract] [Full Text] [Related]
36. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.
Rowe AK; Bertolli J; Khan AS; Mukunu R; Muyembe-Tamfum JJ; Bressler D; Williams AJ; Peters CJ; Rodriguez L; Feldmann H; Nichol ST; Rollin PE; Ksiazek TG
J Infect Dis; 1999 Feb; 179 Suppl 1():S28-35. PubMed ID: 9988162
[TBL] [Abstract][Full Text] [Related]
37. [Development and study of the properties of immunoglobulin against Ebola fever].
Borisevich IV; Mikhaĭlov VV; Krasnianskiĭ VP; Gradoboev VN; Lebedinskaia EV; Potryvaeva NV; Timan'kova GD
Vopr Virusol; 1995; 40(6):270-3. PubMed ID: 8686265
[TBL] [Abstract][Full Text] [Related]
38. INFECTIOUS DISEASES. Surviving Ebola survival.
Kupferschmidt K
Science; 2015 Jun; 348(6242):1406-7. PubMed ID: 26113694
[No Abstract] [Full Text] [Related]
39. Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985.
Jezek Z; Szczeniowski MY; Muyembe-Tamfum JJ; McCormick JB; Heymann DL
J Infect Dis; 1999 Feb; 179 Suppl 1():S60-4. PubMed ID: 9988166
[TBL] [Abstract][Full Text] [Related]
40. Ebola vaccine gets corporate backer.
Dove A
Nat Med; 2002 Jul; 8(7):645-6. PubMed ID: 12091886
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
